Samodzielny Publiczny Szpital Kliniczny Nr 1 Im.Prof.Stanislawa Szyszko Slaskiego Uniwersytetu Medycznego W Katowicach

At Samodzielny Publiczny Szpital Kliniczny Nr 1 Im.Prof.Stanislawa Szyszko Slaskiego Uniwersytetu Medycznego W Katowicach, research in gastroenterology focuses on ulcerative colitis and Crohn’s disease, with additional work in related inflammatory bowel conditions. These trials are designed to assess new and existing therapies, aiming to improve symptom control, long-term safety, and treatment effectiveness in both pediatric and adult patients.

• Inflammatory bowel disease, including ulcerative colitis and Crohn’s disease
• Immune system diseases and treatment response in chronic inflammation
• Evaluation of therapies to improve disease control and safety

This area includes studies of biologic and supportive treatments intended to better manage ongoing intestinal inflammation and improve quality of life.

The site has a strong neurology portfolio, especially in multiple sclerosis and other autoimmune disorders affecting the nervous system. Research includes trials for relapsing and progressive forms of disease, as well as studies in myasthenia gravis, autoimmune encephalitis, MOGAD, and refractory status epilepticus, with the goal of testing new therapies and refining disease control.

• Multiple sclerosis, including relapsing and progressive forms
• Myasthenia gravis and other autoimmune neuromuscular disorders
• Autoimmune encephalitis, MOGAD, and seizure-related conditions

These studies aim to improve neurological outcomes, reduce relapse risk, and expand options for patients with difficult-to-treat immune-mediated neurologic disease.

A major research focus is pediatric hematology and oncology, including acute lymphoblastic leukemia, acute myeloid leukemia, lymphoblastic lymphoma, and primary malignant liver tumors such as hepatoblastoma. Trials at the site are aimed at improving survival, reducing treatment-related toxicity, and identifying more effective approaches for children and adolescents with cancer.

• Acute lymphoblastic leukemia and lymphoblastic lymphoma
• Acute myeloid leukemia, including high-risk and relapsed disease
• Hepatoblastoma and other pediatric liver cancers

This research supports better risk-adapted treatment and more precise care for young patients facing serious blood and solid tumors.

The clinical trial program also covers metabolic and endocrine diseases, with studies in type 2 diabetes, obesity, overweight, vitamin D deficiency, and congenital adrenal hyperplasia. These trials are designed to evaluate therapies that may improve blood sugar control, support weight management, and address hormone-related disorders.

• Type 2 diabetes and related complications
• Obesity and overweight in adults and adolescents
• Congenital adrenal hyperplasia and vitamin D3 deficiency

The research here is centered on testing new treatment options and understanding how they may help patients achieve better long-term metabolic health.

Another active area involves cardiovascular and kidney disease, along with research in perioperative care. Trials include patients with atherosclerotic disease, myocardial injury after noncardiac surgery, chronic kidney disease, and atypical hemolytic uremic syndrome, reflecting a broad interest in improving outcomes across internal medicine and surgical settings.

• Cardiovascular disease and surgery-related heart injury
• Chronic kidney disease and proteinuria-related outcomes
• Atypical hemolytic uremic syndrome and other complement-mediated conditions

These studies are focused on evaluating treatments that may reduce complications, protect organ function, and improve recovery after surgery.

The site also participates in trials across respiratory disease, pain management, and supportive care. Research includes chronic obstructive pulmonary disease, diabetic peripheral neuropathic pain, and general anesthesia, with an emphasis on improving everyday clinical care and patient comfort.

• Chronic obstructive pulmonary disease
• Neuropathic pain and symptom relief
• Anesthesia and peri-procedural care

These studies often examine whether new approaches can make treatment safer, more effective, or easier for patients to tolerate.